Analyst Report: INTC
1. EXECUTIVE SUMMARY
Intel fell 35.41% over the week to a $60.55 close on 3 November 2026, from $93.74 on 27 October. The damage came from fourth-quarter guidance issued after the close on 29 October. Intel guided revenue of $15.0bn to $16.0bn and non-GAAP EPS of $0.25, and finance chief David Zinsner told investors the PC slowdown will continue "at least through the first half of next year" (CNBC). The stock lost 28.58% on 30 October on 455.6 million shares, then fell another 8.80% on 2 November before edging up 0.97% on 3 November. The third quarter itself beat expectations, so the sell-off rests on the outlook for PC chips and memory-driven demand weakness. The shares still trade at a forward P/E of 33.7 and sit above their 52-week low, while analysts have cut targets broadly, with most ratings at Neutral or Hold.
2. THE CATALYST
Intel published Q3 2026 results after the close on 29 October (Intel 8-K press release). Revenue was $16.5bn, up 21% year over year, and non-GAAP EPS was $0.52 against an estimate of $0.40 (Intel 8-K; Heygotrade). Operating cash flow was $5.1bn (Intel 8-K).
The guidance caused the sell-off. Intel forecast Q4 revenue of $15.0bn to $16.0bn, EPS attributable to Intel of $0.10 and non-GAAP EPS of $0.25 (Intel 8-K). Memeburn put the revenue guide about 9% below the $17.07bn analysts expected. Reuters, as cited by Heygotrade, reported that Intel expects PC chip revenue to fall in the mid-20% range in Q4. CEO Lip-Bu Tan described an "unprecedented memory crunch" weighing on PC demand (TheStreet). Heygotrade, a single secondary source, also reported an Israel factory incident that would remove about $600 million of revenue over two quarters; this is unconfirmed.
| Session | Close | Move | Volume |
|---|---|---|---|
| 29 Oct (earnings after close) | $92.07 | -3.62% | 134.2m |
| 30 Oct | $65.76 | -28.58% | 455.6m |
| 2 Nov | $59.97 | -8.80% | 230.7m |
| 3 Nov | $60.55 | +0.97% | 147.2m |
The stock fell more than 20% in extended trading on 29 October (CNBC), and the full reaction arrived in the 30 October session. Headlines from CNBC and Yahoo Finance described 30 October as Intel's worst day since the 1970s; I have not seen the underlying articles, and these are headline-only claims.
3. COMPANY PROFILE
Intel designs, manufactures and sells computing products through three segments: CCG (client CPUs and related products), DCAI (server CPUs, GPUs and networking) and Intel Foundry. It competes with AMD and Nvidia in processors and accelerators, and has a foundry business that fabricates chips. Its market cap is $321.82bn.
The shares gained about 150% year to date before the report, driven by server CPU demand from agentic AI (Motley Fool). Intel completed a $23bn equity offering in August (secondary source). The CEO said CPU demand remains robust and that the immediate priority is adding Xeon supply (Intel 8-K). Next earnings are due on 28 January 2027, with consensus at $0.25 EPS and $15.67bn revenue.
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The reported quarter was strong, with 21% revenue growth and EPS 30% above the estimate ($0.52 against $0.40). The loss in value comes from the guide. A Q4 revenue midpoint of $15.5bn falls below the $17.07bn consensus, and the $15.67bn estimate now in the facts panel sits near the top of the new range. An analyst note cited by CNBC said PC shipments could fall 25% to 30% quarter over quarter in Q4, with further inventory correction in the first half of 2027. If that proves right, the weakness extends well beyond one quarter, which supports a lower multiple for the PC business. The server side, by management's account, is supply-constrained rather than demand-constrained.
Analyst reaction. Targets were cut across the Street on 30 October.
| Broker | Action | Rating |
|---|---|---|
| Jefferies | $120 to $85 | n/a |
| Piper Sandler | $110 to $90 | n/a |
| JPMorgan | $85 to $80 | Neutral |
| Goldman Sachs | $150 to $100 | Neutral |
| Wells Fargo | $120 to $80 | Equal weight |
| Truist | $108 to $72 | Hold |
| Cantor Fitzgerald | $125 to $90 | Neutral |
| Barclays | $100 to $75 | Equal weight |
| Bank of America | Downgrade | Neutral |
| Northland | $93 target | n/a |
TD Cowen's cut from $95 to $75 comes from one source (GuruFocus). UBS is reported as Neutral with an $80 target by CNBC and as a downgrade to Hold with a $90 target by MarketBeat, so its position is unresolved. RBC reports conflict between Barchart and MarketBeat and are left out. MarketBeat's consensus is Hold with an average target of about $100.53, which is likely to lag the cuts. The $60.55 close sits below every target listed above.
Peers. Over the same period MRVL fell 29.40% and AMD fell 13.63%, while MU lost 7.93%, NVDA 5.16% and AVGO 2.98%. TXN rose 1.65%. The S&P 500 fell 1.99%. Reuters, via Heygotrade, reported the semiconductor index selling off after the close on 29 October, and Yahoo headlines described a broad chip rout. AMD reported on 3 November, and headlines say it beat estimates with strong data center results; these are headline-only items. Inference: the PC and memory warning dragged on chip names with exposure to the same cycle, while Intel took the heaviest damage.
Bull case. Revenue grew 21%, cash generation was solid, and server demand exceeds supply. The shares have already lost 46.18% in 20 sessions and are 57.5% below the June high of $142.35. The stock is up 53.76% year to date even after the fall.
Bear case. PC weakness is guided through the first half of 2027. The forward P/E of 33.7 leaves little cushion if estimates fall further. The shares trade below both the 50-day and 200-day averages, and the equity offering in August adds to the share count.
5. TECHNICAL SNAPSHOT
At $60.55 the shares sit below the 50-day average of $99.97 and the 200-day average of $86.99, and 57.5% beneath the 52-week high of $142.35, though well above the 52-week low of $32.89. The nearest support is the 2 November close of $59.97, which is also near the 3 November intraday low of $59.87. The nearest resistance is the 30 October close of $65.76. Volume reached 455.6 million on 30 October, about four times the 50-session average of 110.5 million, and fell to 147.2 million on 3 November, 1.33 times the average. The slowing volume and the small gain on 3 November suggest selling pressure has eased, though a single session does not establish a base.
6. RISK FACTORS
- Further PC demand deterioration, with an analyst note citing shipment declines of 25% to 30% in Q4 and more inventory correction in the first half of 2027.
- Memory shortages, which the CEO described as unprecedented, continuing to limit PC builds.
- The reported Israel factory incident, which would remove about $600 million of revenue over two quarters if confirmed.
- Estimate cuts that push EPS below the current $0.25 consensus for the next report.
- Analyst downgrades beyond Bank of America's, since the average rating is already Hold.
- Peer earnings and sector sentiment, given the broad chip sell-off.
Dated catalyst: Intel's next earnings report on 28 January 2027.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks): The stock has stabilised near $60 after three sessions of heavy trading. The $59.97 close is the level to watch on the downside and $65.76 on the upside. Read-through from AMD's 3 November results and remaining analyst revisions will drive direction, with no Intel-specific catalyst scheduled.
Medium term (1-3 months): Price action depends on evidence for the PC inventory cycle and on Xeon supply additions, which management named as the priority. Estimate revisions after the guide will set the earnings base ahead of the 28 January report, where the market will compare results with the $0.25 EPS and $15.67bn revenue consensus.
Long term: The thesis rests on server CPU demand and the foundry business, and the brief contains no evidence that either has weakened. The PC outlook has deteriorated through at least mid-2027, and the valuation now has to be supported by data center growth. This is analysis only and not personal financial advice.